LUXTURNA
LUXTURNA
Approved
DIN Number
02505851
Drug Class
Human
Market Date
Mar 14, 2022
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02505851
AIG Number0162520001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
S01XA27 VORETIGENE NEPARVOVEC
Product Specifications
Dosage FormSolution
Route of AdministrationSubretinal
AHFS Classification26:12.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
VORETIGENE NEPARVOVECActive
Strength: 5000000000000 VG / ML
Monograph: VORETIGENE NEPARVOVEC